Media & Press Updates
Find out BCAL's latest updates and activity
A new way to detect cancer cells is coming to market
BCAL Diagnostics has closed off a $4M pre-IPO capital raise to fund trials of its breast cancer blood test. Chairperson Jayne Shaw says it could revolutionise how we detect cancer cells.
Breast cancer blood test biotech scores fresh funds
The University of Sydney, Sydney Knowledge Hub -One Year of Review-
BCAL Diagnostics partners with Sydney Knowledge Hub And Sydney Mass Spectrometry
April 1, 2020
BCAL Diagnostics Wins "Win The Future" Contest For International Entrepreneurs in Oceania Programme
October 26, 2019
BCAL Diagnostics Presents at Heads Over Heels Melbourne
June 6, 2019
BCAL Diagnostics is a wholly Australian-owned biotechnology company based at the National Innovation Centre at Eveleigh. Since its establishment in 2010, BCAL Diagnostics has been striving to revolutionise early detection and screening for breast cancer for women worldwide.
Amani Batarseh ’03 is a Senior Research Scientist Lipidomics and Mass Spectrometry for BCAL Diagnostics.
The Revolutionary Blood Test for Cancer
BCAL Scientist Dr Dharmica Mistry is one of the Australian scientists behind a groundbreaking discovery that will make it possible to detect breast cancer through a blood test.
Commercial Progress - Carl Stubbings
In August 2016 BCAL Dx welcomed Carl Stubbings to head the company’s commercialisation efforts. Carl has considerable experience in the commercialisation of diagnostic products with a particular focus on the USA.
Dharmica has been nominated for her contribution to life changing medical research around early breast cancer detection that will impact upon women around the world. Dharmica Mistry shares her story. View here
February 17, 2016
Revolutionising the test for breast cancer: Dharmica Mistry on RN Breakfast
My dream is to have this for every woman: The young doctor who made a breast breakthrough – SBS News The Feed
Dr Dharmica Mistry’s eureka moment came during her monthly beauty routine of spraying olive oil in her hair. She realised that oils from the blood of breast cancer patients was being deposited in their hair and that a simple blood test could screen for the disease.
Although the test is not yet on the market, preliminary results show a promising 90 per cent cancer detection rate. and women living in rural areas access breast cancer testing.
Right now, one in eight Australians are living with breast cancer. Today alone, around forty women will be diagnosed with the disease.